or Try an Advanced Search...

    Technical Analysis for MDGL - Madrigal Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    C 321.48 0.04% 0.12
    MDGL closed up 0.88 percent on Tuesday, December 3, 2024, on approximately normal volume.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical MDGL trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.92%
    Down 3 Days in a Row Weakness 0.92%
    Down 4 Days in a Row Weakness 0.92%
    Down 5 Days in a Row Weakness 0.92%
    Fell Below 20 DMA Bearish -2.04%
    NR7 Range Contraction -2.04%
    NR7-2 Range Contraction -2.04%
    Narrow Range Bar Range Contraction -2.04%
    Down 3 Days in a Row Weakness -2.04%
    Down 4 Days in a Row Weakness -2.04%
    Older End-of-Day Signals for MDGL ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 20 hours ago
    60 Minute Opening Range Breakdown about 20 hours ago
    Possible NR7 about 20 hours ago
    Fell Below Previous Day's Low about 24 hours ago
    Up 1% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    MDGL Chart by TradingView
    Basic chart:

    Profile

    Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-' agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medication Lipid Metabolic Disease Endocrine System Cholesterol Thyroid Hypercholesterolemia Dyslipidemia Glands Triglyceride Hyperlipidemia Vascular And Metabolic Diseases

    Is MDGL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 25 Top 3 Health Care Stocks That May Dip This Month
    Nov 23 3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move
    Nov 22 Madrigal (MDGL) Just Flashed Golden Cross Signal: Do You Buy?
    Nov 21 Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024?
    Nov 20 Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra
    Nov 18 The first MASH drug could open the door for others — including GLP-1s
    Nov 15 Madrigal Pharmaceuticals gains amid takeover speculation
    Nov 15 John Paulson's Strategic Moves in Q3 2024: A Focus on Anglogold Ashanti PLC
    Nov 14 Paulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves
    Nov 11 Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance
    See more MDGL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 368.29
    52 Week Low 168.2462
    Average Volume 448,774
    200-Day Moving Average 252.77
    50-Day Moving Average 263.99
    20-Day Moving Average 327.97
    10-Day Moving Average 328.94
    Average True Range 15.50
    RSI (14) 56.71
    ADX 29.67
    +DI 29.99
    -DI 24.99
    Chandelier Exit (Long, 3 ATRs) 321.79
    Chandelier Exit (Short, 3 ATRs) 309.35
    Upper Bollinger Bands 362.20
    Lower Bollinger Band 293.74
    Percent B (%b) 0.4
    BandWidth 20.88
    MACD Line 16.86
    MACD Signal Line 20.82
    MACD Histogram -3.9542
    Fundamentals Value
    Market Cap 6.34 Billion
    Num Shares 19.7 Million
    EPS -19.24
    Price-to-Earnings (P/E) Ratio -16.70
    Price-to-Sales 0.00
    Price-to-Book 168.57
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 334.43
    Resistance 3 (R3) 333.54 328.31 332.25
    Resistance 2 (R2) 328.31 324.98 328.75 331.52
    Resistance 1 (R1) 324.83 322.92 326.57 325.72 330.80
    Pivot Point 319.60 319.60 320.47 320.04 319.60
    Support 1 (S1) 316.12 316.27 317.86 317.01 311.92
    Support 2 (S2) 310.89 314.21 311.33 311.20
    Support 3 (S3) 307.41 310.89 310.47
    Support 4 (S4) 308.30